Category: Introduction To Biostatistics

  • To attribute all changes to the new policy.
  • To urgently highlight the potential for confounding and the need to consider and, if possible, adjust for other concurrent changes.
  • To ignore other factors.
  • To assume the policy is the only cause.
  • To proceed with the small sample size.
  • To urgently advise that an underpowered study is unethical and a waste of resources, as it has a high chance of missing a true effect (Type II error).
  • To only consider the cost of the trial.
  • To assume the drug will work anyway.
  • To accept the mean as the best measure.
  • To urgently recommend using the median as a more robust measure of central tendency for skewed data to avoid misrepresenting the typical income.
  • To ignore the skewness.
  • To only use the mode.
  • To immediately recommend the drug.
  • To urgently explain that while statistically significant, the clinical relevance of such a small effect size is questionable and might not justify the drug's cost or side effects.
  • To only focus on the p-value.
  • To assume statistical significance equals clinical importance.
  • To accept the strong correlation as is.
  • To urgently explain that Pearson's correlation coefficient only measures linear association, and a non-linear relationship might be missed or misinterpreted.
  • To ignore the scatter plot.
  • To assume all relationships are linear.
Scroll to Top